Infectious Disease & Sepsis

I finished Evidence-based Management of Sepsis & Septic Shock! 🚀

I completed Survey: ⏬ Presentations & Evaluation!

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women | New England Journal of Medicine (nejm.org)

Population:

• Study Participants: Adolescent girls and young women in South Africa and Uganda.

• Sample Size: 5338 participants who were initially HIV-negative.

Intervention:

• Primary Intervention: Subcutaneous lenacapavir administered every 26 weeks.

I completed ⏬ Presentations & Evaluation!